Insecticides (India) Ltd — earnings calls
2 quarters summarised from transcripts filed with the exchange, every statement cited. Newest first.
Insecticides (India) Limited reported a 12% year-on-year decline in revenue to INR612 crores for Q1 FY27, with EBITDA down around 20% and PAT margin falling from 8.4% to 7.2%, attributed to a delayed and uneven monsoon that pushed back sowing and crop-protection demand. Management said gross margin still expanded to 31.6% from 29% on a richer premium-product mix, with Maharatna and Focus Maharatna brands now contributing around 64% of B2C business versus 58% a year earlier. The company discussed progress on new product launches with Corteva, ongoing capacity expansion at Dahej and Sotanala, and said it expects stronger execution in the remaining quarters of FY27 as the season normalizes.
Insecticides India Limited reported FY26 revenue of Rs 2,140 crores, up around 7% from Rs 2,000 crores, with EBITDA rising 3% to Rs 227 crores while PAT declined slightly to Rs 139 crores due to higher deferred tax provisions. Q4 revenue grew approximately 19%, led by both B2C and B2B segments, with premium products growing about 24% during the quarter. Management discussed raw material price increases, the Kaeros subsidiary strategy, new product launches with partners Corteva and Nissan, and the addition of Mr. Sanskar Aggarwal to the Board along with a proposed ESOP program.